168 related articles for article (PubMed ID: 34204692)
1. A Biophysical Insight of Camptothecin Biodistribution: Towards a Molecular Understanding of Its Pharmacokinetic Issues.
Almeida A; Fernandes E; Sarmento B; Lúcio M
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34204692
[TBL] [Abstract][Full Text] [Related]
2. Lipid Nanosystems and Serum Protein as Biomimetic Interfaces: Predicting the Biodistribution of a Caffeic Acid-Based Antioxidant.
Fernandes E; Benfeito S; Cagide F; Gonçalves H; Bernstorff S; Nieder JB; Cd Real Oliveira ME; Borges F; Lúcio M
Nanotechnol Sci Appl; 2021; 14():7-27. PubMed ID: 33603350
[TBL] [Abstract][Full Text] [Related]
3. Prediction of paclitaxel pharmacokinetic based on in vitro studies: Interaction with membrane models and human serum albumin.
Carvalho AM; Fernandes E; Gonçalves H; Giner-Casares JJ; Bernstorff S; Nieder JB; Real Oliveira MECD; Lúcio M
Int J Pharm; 2020 Apr; 580():119222. PubMed ID: 32194209
[TBL] [Abstract][Full Text] [Related]
4. Biophysical interaction of temozolomide and its active metabolite with biomembrane models: The relevance of drug-membrane interaction for Glioblastoma Multiforme therapy.
Ramalho MJ; Andrade S; Coelho MÁN; Loureiro JA; Pereira MC
Eur J Pharm Biopharm; 2019 Mar; 136():156-163. PubMed ID: 30682492
[TBL] [Abstract][Full Text] [Related]
5. INTERACTION OF CAMPTOTHECIN WITH HUMAN SERUM ALBUMIN DETERMINED BY FLUORESCENCE ANISOTROPY SPECTROSCOPY.
Wybranowski T; Ziomkowska B; Cyrankiewicz M; Kruszewski S
Acta Pol Pharm; 2016; 73(1):29-34. PubMed ID: 27008798
[TBL] [Abstract][Full Text] [Related]
6. Biophysical and molecular docking insight into interaction mechanism and thermal stability of human serum albumin isoforms with a semi-synthetic water-soluble camptothecin analog irinotecan hydrochloride.
Ishtikhar M; Khan MV; Khan S; Chaturvedi SK; Badr G; Mahmoud MH; Khan RH
J Biomol Struct Dyn; 2016 Jul; 34(7):1545-60. PubMed ID: 26309154
[TBL] [Abstract][Full Text] [Related]
7. Liposomal formulations of poorly soluble camptothecin: drug retention and biodistribution.
Flaten GE; Chang TT; Phillips WT; Brandl M; Bao A; Goins B
J Liposome Res; 2013 Mar; 23(1):70-81. PubMed ID: 23210622
[TBL] [Abstract][Full Text] [Related]
8. In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin.
Watanabe M; Kawano K; Toma K; Hattori Y; Maitani Y
J Control Release; 2008 May; 127(3):231-8. PubMed ID: 18384903
[TBL] [Abstract][Full Text] [Related]
9. [Interaction of camptothecin derivatives with human plasma proteins in vitro].
Kurono Y; Miyajima M; Ikeda K
Yakugaku Zasshi; 1993 Feb; 113(2):167-75. PubMed ID: 8487159
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials.
Chabot GG; Abigerges D; Catimel G; Culine S; de Forni M; Extra JM; Mahjoubi M; Hérait P; Armand JP; Bugat R
Ann Oncol; 1995 Feb; 6(2):141-51. PubMed ID: 7786822
[TBL] [Abstract][Full Text] [Related]
11. The structural basis of camptothecin interactions with human serum albumin: impact on drug stability.
Burke TG; Mi Z
J Med Chem; 1994 Jan; 37(1):40-6. PubMed ID: 8289200
[TBL] [Abstract][Full Text] [Related]
12. Improved tumor targeting and antitumor activity of camptothecin loaded solid lipid nanoparticles by preinjection of blank solid lipid nanoparticles.
Jang DJ; Moon C; Oh E
Biomed Pharmacother; 2016 May; 80():162-172. PubMed ID: 27133053
[TBL] [Abstract][Full Text] [Related]
13. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
Koo OM; Rubinstein I; Onyuksel H
Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
[TBL] [Abstract][Full Text] [Related]
14. Surface-modified silica nanoparticles for tumor-targeted delivery of camptothecin and its biological evaluation.
Botella P; Abasolo I; Fernández Y; Muniesa C; Miranda S; Quesada M; Ruiz J; Schwartz S; Corma A
J Control Release; 2011 Dec; 156(2):246-57. PubMed ID: 21756949
[TBL] [Abstract][Full Text] [Related]
15. The HSA affinity of warfarin and flurbiprofen determined by fluorescence anisotropy measurements of camptothecin.
Wybranowski T; Cyrankiewicz M; Ziomkowska B; Kruszewski S
Biosystems; 2008 Dec; 94(3):258-62. PubMed ID: 18721856
[TBL] [Abstract][Full Text] [Related]
16. Rational Design of a New Self-Codelivery System from Redox-Sensitive Camptothecin-Cytarabine Conjugate Assembly for Effectively Synergistic Anticancer Therapy.
He W; Hu X; Jiang W; Liu R; Zhang D; Zhang J; Li Z; Luan Y
Adv Healthc Mater; 2017 Dec; 6(24):. PubMed ID: 29076266
[TBL] [Abstract][Full Text] [Related]
17. Langmuir monolayers and Differential Scanning Calorimetry for the study of the interactions between camptothecin drugs and biomembrane models.
Casadó A; Giuffrida MC; Sagristá ML; Castelli F; Pujol M; Alsina MA; Mora M
Biochim Biophys Acta; 2016 Feb; 1858(2):422-33. PubMed ID: 26656185
[TBL] [Abstract][Full Text] [Related]
18. PSMA-Oriented Target Delivery of Novel Anticancer Prodrugs: Design, Synthesis, and Biological Evaluations of Oligopeptide-Camptothecin Conjugates.
Xu B; Zhou F; Yan MM; Cai DS; Guo WB; Yang YQ; Jia XH; Zhang WX; Li T; Ma T; Wang PL; Lei HM
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347770
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effect of rifampicin on the biophysical properties of the membranes: significance for therapeutic and side effects.
Pinheiro M; Pisco S; Silva AS; Nunes C; Reis S
Int J Pharm; 2014 May; 466(1-2):190-7. PubMed ID: 24607210
[TBL] [Abstract][Full Text] [Related]
20. Redox sensitive lipid-camptothecin conjugate encapsulated solid lipid nanoparticles for oral delivery.
Du Y; Ling L; Ismail M; He W; Xia Q; Zhou W; Yao C; Li X
Int J Pharm; 2018 Oct; 549(1-2):352-362. PubMed ID: 30099214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
